Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity

Immunity

Volumn 42, Issue 6, 2015, Pages 1171-1184

  Gallo, Paul M ^a   Rapsinski, Glenn J ^a   Wilson, R Paul ^a   Oppong, Gertrude O ^a   Sriram, Uma ^a   Goulian, Mark ^b   Buttaro, Bettina ^a   Caricchio, Roberto ^a   Gallucci, Stefania ^a   Tükel, Çagla ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; AUTOANTIBODY; BACTERIAL DNA; INTERFERON; AMYLOID; BACTERIAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; BIOFILM; CELL ACTIVATION; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS; 129 MOUSE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; NEW ZEALAND BLACK MOUSE; POLYMERIZATION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS;

AMYLOID; ANIMALS; AUTOANTIBODIES; BACTERIAL PROTEINS; BIOFILMS; CELLS, CULTURED; DENDRITIC CELLS; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INTERFERON TYPE I; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, INBRED NZB; POLYMERIZATION; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 84937611284     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.06.002     Document Type: Article

References (85)

1. Alteri C.J., Xicohténcatl-Cortes J., Hess S., Caballero-Olín G., Girón J.A., Friedman R.L. Mycobacterium tuberculosis produces pili during human infection. Proc. Natl. Acad. Sci. USA 2007, 104:5145-5150.
2. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., Shark K.B., Grande W.J., Hughes K.M., Kapur V., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 2003, 100:2610-2615.
3. Barnhart M.M., Chapman M.R. Curli biogenesis and function. Annu. Rev. Microbiol. 2006, 60:131-147.
4. Barrera-Vargas A., Gómez-Martín D., Merayo-Chalico J., Ponce-de-León A., Alcocer-Varela J. Risk factors for drug-resistant bloodstream infections in patients with systemic lupus erythematosus. J.Rheumatol. 2014, 41:1311-1316.
5. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J.Exp. Med. 2003, 197:711-723.
6. Bian Z., Brauner A., Li Y., Normark S. Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis. J.Infect. Dis. 2000, 181:602-612.
7. Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS Suppl. 2013, 121:1-51.
8. Bollinger R.R., Barbas A.S., Bush E.L., Lin S.S., Parker W. Biofilms in the normal human large bowel: fact rather than fiction. Gut 2007, 56:1481-1482.
9. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
10. Bygrave A.E., Rose K.L., Cortes-Hernandez J., Warren J., Rigby R.J., Cook H.T., Walport M.J., Vyse T.J., Botto M. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2004, 2:E243.
11. Chapman M.R., Robinson L.S., Pinkner J.S., Roth R., Heuser J., Hammar M., Normark S., Hultgren S.J. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 2002, 295:851-855.
12. Clynes R., Dumitru C., Ravetch J.V. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998, 279:1052-1054.
13. Collinson S.K., Emödy L., Müller K.H., Trust T.J., Kay W.W. Purification and characterization of thin, aggregative fimbriae from Salmonella enteritidis. J.Bacteriol. 1991, 173:4773-4781.
14. Connolly J.J., Hakonarson H. Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing. J.Biomed. Biotechnol. 2012, 2012:798924.
15. Costa-Reis P., Nativ S., Isgro J., Rodrigues T., Yildirim-Toruner C., Starr A., Saiman L., Imundo L., Eichenfield A. Major infections in a cohortof 120 patients with juvenile-onset systemic lupus erythematosus. Clin. Immunol. 2013, 149:442-449.
16. Crawford R.W., Gibson D.L., Kay W.W., Gunn J.S. Identification of a bile-induced exopolysaccharide required for Salmonella biofilm formation on gallstone surfaces. Infect. Immun. 2008, 76:5341-5349.
17. Crow M.K., Kirou K.A., Wohlgemuth J. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 2003, 36:481-490.
18. Desai D.D., Krishnan M.R., Swindle J.T., Marion T.N. Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. J.Immunol. 1993, 151:1614-1626.
19. Di Domizio J., Dorta-Estremera S., Gagea M., Ganguly D., Meller S., Li P., Zhao B., Tan F.K., Bi L., Gilliet M., Cao W. Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity. Proc. Natl. Acad. Sci. USA 2012, 109:14550-14555.
20. Di Domizio J., Zhang R., Stagg L.J., Gagea M., Zhuo M., Ladbury J.E., Cao W. Binding with nucleic acids or glycosaminoglycans converts soluble protein oligomers to amyloid. J.Biol. Chem. 2012, 287:736-747.
21. Dueholm M.S., Albertsen M., Otzen D., Nielsen P.H. Curli functional amyloid systems are phylogenetically widespread and display large diversity in operon and protein structure. PLoS ONE 2012, 7:e51274.
22. Ehlers M., Fukuyama H., McGaha T.L., Aderem A., Ravetch J.V. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J.Exp. Med. 2006, 203:553-561.
23. Elkon K.B., Stone V.V. Type I interferon and systemic lupus erythematosus. J.Interferon Cytokine Res. 2011, 31:803-812.
24. Feng X., Wu H., Grossman J.M., Hanvivadhanakul P., FitzGerald J.D., Park G.S., Dong X., Chen W., Kim M.H., Weng H.H., et al. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 2006, 54:2951-2962.
25. Fessler B.J. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract. Res. Clin. Rheumatol. 2002, 16:281-291.
26. Fournié G.J., Lambert P.H., Meischer P.A. Release of DNA in circulating blood and induction of anti-DNA antibodies after injection of bacterial lipopolysaccharides. J.Exp. Med. 1974, 140:1189-1206.
27. Gallo P.M., Gallucci S. The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity. Front Immunol 2013, 4:138.
28. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 1999, 5:1249-1255.
29. Gerona J.G., Navarra S.V. Salmonella infections in patients with systemic lupus erythematosus: a case series. Int J Rheum Dis 2009, 12:319-323.
30. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J.Immunol. 2001, 167:1882-1885.
31. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
32. Han G.M., Chen S.L., Shen N., Ye S., Bao C.D., Gu Y.Y. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun. 2003, 4:177-186.
33. Hang L., Slack J.H., Amundson C., Izui S., Theofilopoulos A.N., Dixon F.J. Induction of murine autoimmune disease by chronic polyclonal B cell activation. J.Exp. Med. 1983, 157:874-883.
34. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
35. Hoebe K., Janssen E.M., Kim S.O., Alexopoulou L., Flavell R.A., Han J., Beutler B. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 2003, 4:1223-1229.
36. Hooper L.V., Midtvedt T., Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 2002, 22:283-307.
37. Hufnagel D.A., Tükel C., Chapman M.R. Disease to dirt: the biology of microbial amyloids. PLoS Pathog. 2013, 9:e1003740.
38. Humphries A.D., Raffatellu M., Winter S., Weening E.H., Kingsley R.A., Droleskey R., Zhang S., Figueiredo J., Khare S., Nunes J., et al. The use of flow cytometry to detect expression of subunits encoded by 11 Salmonella enterica serotype Typhimurium fimbrial operons. Mol. Microbiol. 2003, 48:1357-1376.
39. Hung C., Zhou Y., Pinkner J.S., Dodson K.W., Crowley J.R., Heuser J., Chapman M.R., Hadjifrangiskou M., Henderson J.P., Hultgren S.J. Escherichia coli biofilms have an organized and complex extracellular matrix structure. MBio 2013, 4. e00645-00613.
40. Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
41. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
42. Jiménez J.S. Protein-DNA interaction at the origin of neurological diseases: a hypothesis. J.Alzheimers Dis. 2010, 22:375-391.
43. Johnson L., Horsman S.R., Charron-Mazenod L., Turnbull A.L., Mulcahy H., Surette M.G., Lewenza S. Extracellular DNA-induced antimicrobial peptide resistance in Salmonella enterica serovar Typhimurium. BMC Microbiol. 2013, 13:115.
44. Jørgensen T.N., Thurman J., Izui S., Falta M.T., Metzger T.E., Flannery S.A., Kappler J., Marrack P., Kotzin B.L. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice. Genes Immun. 2006, 7:555-567.
45. Kai-Larsen Y., Lüthje P., Chromek M., Peters V., Wang X., Holm A., Kádas L., Hedlund K.O., Johansson J., Chapman M.R., et al. Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog. 2010, 6:e1001010.
46. Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.H., Homey B., Cao W., Wang Y.H., Su B., Nestle F.O., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007, 449:564-569.
47. Larsen P., Nielsen J.L., Dueholm M.S., Wetzel R., Otzen D., Nielsen P.H. Amyloid adhesins are abundant in natural biofilms. Environ. Microbiol. 2007, 9:3077-3090.
48. Lim E., Koh W.H., Loh S.F., Lam M.S., Howe H.S. Non-thyphoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus 2001, 10:87-92.
49. Liu Z., Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat. Med. 2012, 18:871-882.
50. López D., Vlamakis H., Kolter R. Biofilms. Cold Spring Harb. Perspect. Biol. 2010, 2:a000398.
51. Macfarlane S., Dillon J.F. Microbial biofilms in the human gastrointestinal tract. J.Appl. Microbiol. 2007, 102:1187-1196.
52. Macfarlane S., Bahrami B., Macfarlane G.T. Mucosal biofilm communities in the human intestinal tract. Adv. Appl. Microbiol. 2011, 75:111-143.
53. Maldonado M.A., Kakkanaiah V., MacDonald G.C., Chen F., Reap E.A., Balish E., Farkas W.R., Jennette J.C., Madaio M.P., Kotzin B.L., et al. The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J.Immunol. 1999, 162:6322-6330.
54. Mathian A., Weinberg A., Gallegos M., Banchereau J., Koutouzov S. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. J.Immunol. 2005, 174:2499-2506.
55. Merad M., Sathe P., Helft J., Miller J., Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 2013, 31:563-604.
56. Morel L. Genetics of SLE: evidence from mouse models. Nat Rev Rheumatol 2010, 6:348-357.
57. Morel L., Mohan C., Yu Y., Croker B.P., Tian N., Deng A., Wakeland E.K. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J.Immunol. 1997, 158:6019-6028.
58. Moser K.L., Kelly J.A., Lessard C.J., Harley J.B. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun. 2009, 10:373-379.
59. Nagata S., Hanayama R., Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010, 140:619-630.
60. Naiki H., Higuchi K., Nakakuki K., Takeda T. Kinetic analysis of amyloid fibril polymerization invitro. Lab. Invest. 1991, 65:104-110.
61. Nishimori J.H., Newman T.N., Oppong G.O., Rapsinski G.J., Yen J.H., Biesecker S.G., Wilson R.P., Butler B.P., Winter M.G., Tsolis R.M., et al. Microbial amyloids induce interleukin 17A (IL-17A) and IL-22 responses via Toll-like receptor 2 activation in the intestinal mucosa. Infect. Immun. 2012, 80:4398-4408.
62. Nissle A. [Sanitation of intestinal flora as a prophylactic measure]. Medizinische 1957, 10:82-85.
63. O'Toole G.A., Pratt L.A., Watnick P.I., Newman D.K., Weaver V.B., Kolter R. Genetic approaches to study of biofilms. Methods Enzymol. 1999, 310:91-109.
64. Pablos J.L., Aragon A., Gomez-Reino J.J. Salmonellosis and systemic lupus erythematosus. Report of ten cases. Br. J. Rheumatol. 1994, 33:129-132.
65. Petri M. Infection in systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 1998, 24:423-456.
66. Raffatellu M., Chessa D., Wilson R.P., Dusold R., Rubino S., Bäumler A.J. The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa. Infect. Immun. 2005, 73:3367-3374.
67. Rapsinski G.J., Newman T.N., Oppong G.O., van Putten J.P., Tükel C. CD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers. J.Biol. Chem. 2013, 288:14178-14188.
68. Römling U., Bian Z., Hammar M., Sierralta W.D., Normark S. Curli fibers are highly conserved between Salmonella typhimurium and Escherichia coli with respect to operon structure and regulation. J.Bacteriol. 1998, 180:722-731.
69. Schnabel J. Protein folding: The dark side of proteins. Nature 2010, 464:828-829.
70. Schwartz K., Syed A.K., Stephenson R.E., Rickard A.H., Boles B.R. Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS Pathog. 2012, 8:e1002744.
71. Shi L., Zhang Z., Yu A.M., Wang W., Wei Z., Akhter E., Maurer K., Costa Reis P., Song L., Petri M., Sullivan K.E. The SLE transcriptome exhibits evidence of chronic endotoxin exposure and has widespread dysregulation of non-coding and coding RNAs. PLoS ONE 2014, 9:e93846.
72. Sriram U., Varghese L., Bennett H.L., Jog N.R., Shivers D.K., Ning Y., Behrens E.M., Caricchio R., Gallucci S. Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset. J.Immunol. 2012, 189:80-91.
73. Stojiljkovic I., Bäumler A.J., Heffron F. Ethanolamine utilization in Salmonella typhimurium: nucleotide sequence, protein expression, and mutational analysis of the cchA cchB eutE eutJ eutG eutH gene cluster. J.Bacteriol. 1995, 177:1357-1366.
74. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443-451.
75. Tan E.M. Autoantibodies, autoimmune disease, and the birth of immune diagnostics. J.Clin. Invest. 2012, 122:3835-3836.
76. Tsao C.H., Chen C.Y., Ou L.S., Huang J.L. Risk factors of mortality for salmonella infection in systemic lupus erythematosus. J.Rheumatol. 2002, 29:1214-1218.
77. Tükel C., Raffatellu M., Humphries A.D., Wilson R.P., Andrews-Polymenis H.L., Gull T., Figueiredo J.F., Wong M.H., Michelsen K.S., Akçelik M., et al. CsgA is a pathogen-associated molecular pattern of Salmonella enterica serotype Typhimurium that is recognized by Toll-like receptor 2. Mol. Microbiol. 2005, 58:289-304.
78. Tükel C., Wilson R.P., Nishimori J.H., Pezeshki M., Chromy B.A., Bäumler A.J. Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2. Cell Host Microbe 2009, 6:45-53.
79. Tükel C., Nishimori J.H., Wilson R.P., Winter M.G., Keestra A.M., van Putten J.P., Bäumler A.J. Toll-like receptors 1 and 2 cooperatively mediate immune responses to curli, a common amyloid from enterobacterial biofilms. Cell. Microbiol. 2010, 12:1495-1505.
80. Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The human microbiome project. Nature 2007, 449:804-810.
81. Turner J.R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 2009, 9:799-809.
82. von Rosenvinge E.C., O'May G.A., Macfarlane S., Macfarlane G.T., Shirtliff M.E. Microbial biofilms and gastrointestinal diseases. Pathog Dis 2013, 67:25-38.
83. Walker T.S., Tomlin K.L., Worthen G.S., Poch K.R., Lieber J.G., Saavedra M.T., Fessler M.B., Malcolm K.C., Vasil M.L., Nick J.A. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect. Immun. 2005, 73:3693-3701.
84. Wang X., Smith D.R., Jones J.W., Chapman M.R. Invitro polymerization of a functional Escherichia coli amyloid protein. J.Biol. Chem. 2007, 282:3713-3719.
85. Whitchurch C.B., Tolker-Nielsen T., Ragas P.C., Mattick J.S. Extracellular DNA required for bacterial biofilm formation. Science 2002, 295:1487.